Juthamas Sukbuntherng

Pharmacyclics (United States) · US

Area of research

Genetics · Pathology and Forensic Medicine

Research interest

Research interests include Chronic Lymphocytic Leukemia Research, Lymphoma Diagnosis and Treatment, PI3K/AKT/mTOR signaling in cancer, and Monoclonal and Polyclonal Antibodies Research.

h-index

citations

7,339

works

NIH funding

—

primary concept

—

✉ Find email ↗

Recent publications

Ibrutinib (Ibr) Plus Venetoclax (Ven) for First-Line Treatment of Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL): Results from the MRD Cohort of the Phase 2 CAPTIVATE Study

Blood 2019cited by 41position: middledoi

Impact of ibrutinib dose adherence on therapeutic efficacy in patients with previously treated CLL/SLL

Blood 2017cited by 142position: middledoi

Abstract B19: Population pharmacokinetic-pharmacodynamic (PKPD) modeling of ibrutinib in patients with B-cell malignancies.

Clinical Cancer Research 2015cited by 3position: middledoi

Targeting BTK with Ibrutinib in Relapsed Chronic Lymphocytic Leukemia

New England Journal of Medicine 2013cited by 2,247position: middledoi

Bruton Tyrosine Kinase Inhibitor Ibrutinib (PCI-32765) Has Significant Activity in Patients With Relapsed/Refractory B-Cell Malignancies

Journal of Clinical Oncology 2012cited by 1,113position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Danelle F. James · Freedom House4 papers (2013–2019)Richard R. Furman · Cornell University3 papers (2012–2017)Betty Chang · Vyne Therapeutics (United States)3 papers (2012–2015)John C. Byrd · The University of Texas Southwestern Medical Center3 papers (2013–2017)Susan O’Brien · University of California, Irvine3 papers (2013–2017)Jeff P. Sharman · Sarah Cannon2 papers (2012–2013)Steven Coutré · Stanford University2 papers (2013–2017)Eric Hedrick · Biogen (United States)2 papers (2012–2013)Paul M. Barr · University of Rochester Medical Center2 papers (2017–2019)Jan A. Burger · The University of Texas MD Anderson Cancer Center2 papers (2013–2017)Ranjana H. Advani · Stanford Medicine2 papers (2012–2015)Joseph J. Buggy · Collaborative Drug Discovery (United States)2 papers (2012–2013)William G. Wierda · The University of Texas MD Anderson Cancer Center2 papers (2013–2019)Barbara Grant · University of Vermont2 papers (2012–2013)Ian W. Flinn · Centennial Medical Center2 papers (2013–2019)Florence Cymbalista · Equipe de Recherche en Epidémiologie Nutritionnelle1 papers (2017–2017)Fong Clow · AbbVie (United States)1 papers (2013–2013)Giuseppe De Nicolao · University of Pavia1 papers (2015–2015)Italo Poggesi · University Hospital Heidelberg1 papers (2015–2015)Amy J. Johnson · The Ohio State University1 papers (2013–2013)